資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34402
|
| 標題: | Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials |
| 作者: | Lin, Yu-Hsuan
Lin, Yueh-Chien
Chen, Chien-Chin |
| 貢獻者: | Natl Sun Yat Sen Univ, Inst Biomed Sci
Kaohsiung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg
Natl Yang Ming Chiao Tung Univ, Sch Med
Chung Shan Med Univ, Sch Med
Natl Taiwan Univ, Dept Life Sci
Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Vasc Biol Program
Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Pathol
Chia Nan Univ Pharm & Sci, Dept Cosmet Sci |
| 關鍵字: | antagonist
cancer
clinical trial
lysophosphatidic acid
lysophosphatidic receptor
therapy |
| 日期: | 2021 |
| 上傳時間: | 2023-11-11 11:49:53 (UTC+8) |
| 出版者: | MDPI |
| 摘要: | Lysophosphatidic acid (LPA) is a bioactive lipid mediator primarily derived from membrane phospholipids. LPA initiates cellular effects upon binding to a family of G protein-coupled receptors, termed LPA receptors (LPAR1 to LPAR6). LPA signaling drives cell migration and proliferation, cytokine production, thrombosis, fibrosis, angiogenesis, and lymphangiogenesis. Since the expression and function of LPA receptors are critical for cellular effects, selective antagonists may represent a potential treatment for a broad range of illnesses, such as cardiovascular diseases, idiopathic pulmonary fibrosis, voiding dysfunctions, and various types of cancers. More new LPA receptor antagonists have shown their therapeutic potentials, although most are still in the preclinical trial stage. This review provided integrative information and summarized preclinical findings and recent clinical trials of different LPA receptor antagonists in cancer progression and resistance. Targeting LPA receptors can have potential applications in clinical patients with various diseases, including cancer. |
| 關聯: | CELLS-BASEL, v.10, n.7, 1629 |
| 顯示於類別: | [化妝品應用與管理系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| cells10071629.pdf | | 1057Kb | Adobe PDF | 74 | 檢視/開啟 | | index.html | | 0Kb | HTML | 280 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
